Ventas, Inc. (NYSE:VTR) has received an average recommendation of “Hold” from the seventeen brokerages that are covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $68.50.
Several equities research analysts have weighed in on VTR shares. BMO Capital Markets reissued a “hold” rating and set a $73.00 price target on shares of Ventas in a research report on Monday, July 29th. ValuEngine cut shares of Ventas from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Barclays started coverage on shares of Ventas in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $74.00 price target for the company. Morgan Stanley increased their price target on shares of Ventas from $61.00 to $73.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 17th. Finally, Berenberg Bank started coverage on shares of Ventas in a research report on Thursday, September 12th. They set a “hold” rating and a $72.00 price target for the company.
VTR traded down $0.71 during trading on Monday, hitting $72.47. 1,229,400 shares of the stock traded hands, compared to its average volume of 2,057,751. The firm has a market capitalization of $27.05 billion, a P/E ratio of 17.81, a price-to-earnings-growth ratio of 6.20 and a beta of 0.22. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a 50-day moving average of $72.87 and a 200 day moving average of $68.22. Ventas has a 12-month low of $55.64 and a 12-month high of $75.40.
The business also recently disclosed a — dividend, which was paid on Friday, October 11th. Shareholders of record on Tuesday, October 1st were issued a $0.7925 dividend. The ex-dividend date of this dividend was Monday, September 30th. This represents a yield of 4.4%. Ventas’s dividend payout ratio (DPR) is presently 77.89%.
In other Ventas news, EVP John D. Cobb sold 10,000 shares of the company’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $72.54, for a total value of $725,400.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.40% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the business. Kavar Capital Partners LLC bought a new position in Ventas in the 2nd quarter worth $27,000. HM Payson & Co. bought a new position in shares of Ventas in the 2nd quarter worth about $29,000. Gradient Investments LLC increased its stake in shares of Ventas by 1,007.7% in the 2nd quarter. Gradient Investments LLC now owns 432 shares of the real estate investment trust’s stock worth $30,000 after acquiring an additional 393 shares in the last quarter. Optimum Investment Advisors increased its stake in shares of Ventas by 77.1% in the 3rd quarter. Optimum Investment Advisors now owns 496 shares of the real estate investment trust’s stock worth $36,000 after acquiring an additional 216 shares in the last quarter. Finally, Institutional & Family Asset Management LLC increased its stake in shares of Ventas by 140.4% in the 2nd quarter. Institutional & Family Asset Management LLC now owns 661 shares of the real estate investment trust’s stock worth $45,000 after acquiring an additional 386 shares in the last quarter. Institutional investors and hedge funds own 87.42% of the company’s stock.
Ventas Company Profile
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, university-based research and innovation centers, inpatient rehabilitation and long-term acute care facilities, and health systems.
Further Reading: Hedge Funds – Risk or Reward?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.